Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

A propos de Lite Strategy

Fondé2018

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Communauté
Twitter
Website
Étiquettes
Publicly listed company
Crypto Stocks

Trend of Hot Index Change

Détails du financement

Post-IPO(2025-07-21)
Montant€86,72M
Estimation--